Entod Pharmaceuticals

What Entod Pharmaceuticals does

Entod Pharmaceuticals Ltd is an India-based, family-owned specialty pharmaceutical company founded in 1977, headquartered in Mumbai with corporate offices in Navi Mumbai and operations across 67+ countries. The company develops and manufactures prescription medicines in three therapeutic verticals — ophthalmology, ear-nose-throat (ENT), and dermatology — with a portfolio of more than 300 finished products including eye drops, intracameral injectables, ear drops, nasal sprays, gel serums, creams, ointments and oral dosage forms. Notable products include CYCLOTEARS (SEDDS-based inflammatory eye drops), PresVu (first-in-India pilocarpine eye drops for presbyopia), MYATRO XL (atropine eye drops for myopia control), PHENOCAINE PLUS (intracameral injection for cataract surgery) and COLLADERM (AI-bio-engineered collagen serum). Proprietary technology platforms include the Self-Emulsifying Drug Delivery System (SEDDS), the Stabilised Oxychloro Complex (SOC) ophthalmic preservative licensed through a wholly-owned UK R&D subsidiary (Entod Research Cell UK / ERC Labs) and Medisearch Laboratories, and an AI-bio-engineering platform used in dermatology product development.

The business operates a prescription-led, sales-driven model rather than OTC or direct-to-consumer primary distribution: more than 1,500 field-based representatives cover all Indian states, with parallel international export operations under ENTOD International reaching the UK, EU, Africa and Asia. In India, finished formulations are subject to NPPA drug-pricing regulation; internationally, products are sold through regulated export channels against prescriptions of registered practitioners. Adjacent revenue streams include specialty excipients (the SOC preservative is supplied to third-party eye-drop manufacturers globally) and a minority stake in the D2C ocular-aesthetics brand Eyecirque. Manufacturing facilities are US FDA, MHRA and WHO GMP certified; quality systems are ISO 9001:2015, ISO 13485:2016 and ISO 22716 certified. Founder-controlled by the Masurkar family, with CEO Nikkhil K Masurkar (a Kings College London-trained research pharmacist) and Chairman Kishore Masurkar, the company also runs an academic engagement platform (ENTOMEET, 2,000+ webinars) and digital adherence tools (iAssist, OpenRx Timer mobile apps) directed at ophthalmologists, ENT specialists, dermatologists and their patients.

Name

Entod Pharmaceuticals

Legal name

ENTOD Pharmaceuticals Ltd

Website

https://entodpharma.com

Company type

Private

Founded year

1977

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Entod Pharmaceuticals is a Mumbai-based, family-owned specialty pharmaceutical company founded in 1977 that develops and manufactures prescription ophthalmic, ENT and dermatology medicines across 67+ countries, serving patients via 1,500+ field-sales representatives in India and regulated export channels internationally.

Ownership category

akta.pro rank

Product category

Specialty Pharmaceuticals (Ophthalmology, ENT, Dermatology)

NAICS

Pharmaceutical Preparation Manufacturing (325412), Ophthalmic Goods Manufacturing (339115), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834), Ophthalmic Goods (3851), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Ophthalmology Specialty Pharmaceuticals (HLAIACAK)

akta.pro secondary industries

Dermatology Specialty Pharmaceuticals (HLAIACAL), Ophthalmology Pharmaceuticals (HLAIAAAL), Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK), Ocular Drug Delivery Devices (Eye Droppers/Inserts) (HLAHAIAL)

Keywords

• Ophthalmic pharmaceuticals
• ENT medicines
• Dermatology formulations
• Specialty drug delivery
• Prescription pharmaceuticals

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Pharmaceutical Products Sales: Sale of prescription pharmaceutical products including ophthalmic, ENT and dermatology medicines. Products are sold only against prescription of registered medical practitioners and are available globally in over 67 countries.
2. Specialty Contract Manufacturing: Contract manufacturing services for pharmaceutical companies in ophthalmic and ENT segments, which the company provided until late 1990s before transitioning to branded medicines.
3. Speciality Excipients: Supply of Stabilised Oxychloro Complex (SOC) and formulation development support for inclusion of SOC in ophthalmic preparations. Technical know-how for SOC and its formulation development.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels9 records

Core offering

Entod Pharmaceuticals manufactures and globally distributes over 300 prescription-only specialty pharmaceutical products across three therapeutic verticals: ophthalmic (eye drops, ointments, gels, intracameral injectables for dry eyes, glaucoma, infections, myopia, presbyopia, cataract surgery support), ENT (ear drops, nasal sprays, hearing supplements for infections, congestion, tinnitus), and dermatology (creams, lotions, gel serums for eczema, acne, ageing skin, ocular aesthetics). The company operates its own DSIR- and FDA-approved R&D facilities, US FDA/MHRA/WHO GMP-certified manufacturing plants, and a 1,500+ strong field sales force covering all Indian states plus international export operations spanning 67+ countries, supplemented by secondary revenue from supply of its proprietary SOC ophthalmic preservative to other formulators.

Product overview

Entod Pharmaceuticals is an international research-based pharmaceutical company specialising in Ophthalmic, ENT and Dermatological medicines with over four decades of experience. The product portfolio includes over 300 finished products across multiple dosage forms: eye drops, eye ointments, eye gels, intracameral injectables, ear drops, nasal sprays, gel serums, creams, ointments, lotions, and oral medications. Key ophthalmic products include CYCLOTEARS (SEDDS-based inflammatory eye disease treatment), PresVu (presbyopia eye drops), MYATRO XL (myopia control in children), and PHENOCAINE PLUS (intracameral injection for cataract surgery). The dermatology range features COLLADERM (AI bio-engineered collagen serum), Eyecirque/Lashfactor/Vasuki (nanotechnology-based ocular aesthetic products), and neurotoxin-based anti-aging treatments. ENT products include Audiovit (hearing supplement), ear wax removal spray, and anti-allergy probiotics. The company also offers digital health tools (iAssist and OpenRx Timer apps) and educational YouTube channels. All products require prescription and are sold in over 67 countries including EU, UK, Africa, and Asia.

Differentiator

Problem solved

Functional benefit

Brands

• Eyecirque: Nanotechnology-based eye, skin and mind wellness D2C healthcare brand offering gel serums and eye supplements for ocular aesthetics.
• Lashfactor
• Vasuki
• ENTOD Beauty
• Fur by Entod
• PresVu
• MYATRO XL
• PHENOCAINE Plus
• COLLADERM
• CYCLOTEARS

Products and services

• CYCLOTEARS Eye Drops Prescription eye drops for inflammatory eye diseases using proprietary SEDDS (Self-Emulsifying Drug Delivery System) technology to enhance bioavailability of active pharmaceutical ingredients. Launched globally in May 2023 for ophthalmic use.
• PresVu (Pilocarpine 1.25%) Prescription eye drops (Pilocarpine 1.25%) for the treatment of presbyopia in adults, with first-in-India DCGI approval following Phase III clinical trial completion.
• MYATRO XL (Atropine 0.05%) Atropine 0.05% eye drops developed to slow down myopia (short-sightedness) in children and help keep their prescription numbers in check; Phase III clinical trial completed.
• PHENOCAINE PLUS Intracameral anaesthetic mydriatic (ICAM) injection used during cataract removal surgery to keep the eye dilated, reduce immediate post-operative pain, and cut down surgery and waiting times for patients; Phase IV clinical trial completed.
• Antibiotic Eye Injection (Post-Cataract) Antibiotic eye injection administered at the end of cataract eye removal procedures to prevent post-surgery infections and improve patient safety.
• COLLADERM AI-driven bio-engineered collagen skin serum for multi-layered skin regeneration, developed in the UK using advanced AI bio-engineering and further optimised at ENTOD's DSIR-approved R&D centre in India; prescription-led and exclusively available through specialist dermatologist clinics.
• Eyecirque Nanotechnology-based gel serums and eye supplements for ocular aesthetics using nano-enabled delivery for improved absorption and performance in eye care applications.
• Lashfactor Nanotechnology-based ocular aesthetic product brand for lash enhancement and eye area care, marketed under the Eyecirque product line.
• Vasuki Nanotechnology-based ocular aesthetic product line for eye area treatments, marketed under the Eyecirque product line.
• Neurotoxin-based Facial Gel Serum Proprietary neurotoxin-based facial gel serum designed to help reduce fine lines and expression wrinkles in early ageing skin through a novel injection-free approach.
• 3D Moisturising Facial Gel Cream Advanced moisturising facial gel cream for skincare applications within the ENTOD Beauty dermatology range.
• Silicone-based Ultra Matte Sunscreen Gel Silicone-based ultra matte sunscreen gel for facial protection within the skincare range.
• Audiovit (Plant-based Antioxidant Supplement) Specialised plant-based antioxidant oral supplement developed to improve hearing and promote good ear health.
• Micellar Ear Wax Removal Spray Micellar formulation in spray form for ear wax removal.
• Electrolytic Artificial Saliva Spray Electrolytic artificial saliva spray for oral/dry mouth conditions.
• Anti-allergy Probiotic (Nasal Flora) Anti-allergy probiotic oral supplement for healthier nasal flora.
• Adaptogenic Cognitive Performance Enhancer Adaptogenic oral supplement designed to help boost memory, mood, focus and reduce brain fog.
• Zincocid (Decongestant) Innovative non-drowsy decongestant with antihistamine combination for nasal congestion, acute allergic rhinitis and restoring functional energy.
• Stabilised Oxychloro Complex (SOC) Ophthalmic Preservative High-purity specialty pharmaceutical excipient developed as an ophthalmic preservative, supplied globally for inclusion in eye drop formulations. Physically compatible with soft contact lenses, meets European Pharmacopeia Criteria B for ophthalmic preservatives, and is considered non-cytotoxic and non-irritant. Provided with formulation development support and technical know-how for SOC-based formulations.
• Fur by Entod (Veterinary Eye Care) Ophthalmic veterinary division offering quality eye care products for pets under the Fur by Entod brand.

Named customers5 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Entod Research Cell UK Ltd (ERC Labs)coreTechnology or IntegrationInternational research partner specializing in the development and production of High Purity Laboratory Reagents and Specialized Pharmaceutical Excipients including the Stabilised Oxychloro Complex (SOC) ophthalmic preservative.
• Medisearch Laboratories (Bombay) Pvt LtdcoreTechnology or IntegrationResearch partner specializing in the development and production of High Purity Laboratory Reagents and Specialized Pharmaceutical Excipients. Provides formulation development support for inclusion of SOC in ophthalmic preparations. One of the few companies globally with full technical know-how of SOC and its formulation development.
• Medical Associations (AIOS, SPOSI, CSI, AOI)coreStrategic or Co-development PartnerPartnership with leading ophthalmology, ENT and dermatology medical associations to develop clinical guidelines, support academic conferences, and advance medical education programmes.
• Leading Medical Colleges & InstitutionscoreStrategic or Co-development PartnerPartnership with leading training medical colleges and institutions to support offline and online ophthalmic post-graduate training programmes.
• Eyecirque Eye, Skin & Mind WellnessminorStrategic or Co-development PartnerEntod owns a stake and provides technical assistance to one of India's leading D2C healthcare brand for eye, skin and mind wellness products.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Sun Pharmaceutical Industries: India's largest pharma company with a substantial ophthalmic specialty franchise (including prescription eye drops and post-surgical products). Directly comparable as an India-headquartered specialty pharma competing in ophthalmic and ENT segments with global distribution.
• Cipla: Major Indian pharma with a meaningful ophthalmic and respiratory/ENT portfolio, including eye drops and nasal sprays. Comparably large field force, broad specialty product range, and global export footprint overlapping Entod's business.
• Ajanta Pharma: India-based specialty pharma with ophthalmic, ENT, and dermatology segments and significant emerging-market exports. Closely comparable in scale, therapeutic mix, and India-centric GTM motion.
• Lupin Pharmaceuticals: India-headquartered pharma with an ophthalmic product line and a sizable domestic field force. Overlap with Entod in branded specialty eye care and ENT prescription products.
• Glenmark Pharmaceuticals: Indian specialty pharma active in dermatology and respiratory/ENT with growing emerging-market presence. Comparable in therapeutic focus areas and India-anchored commercial model.
• FDC Limited: India-based pharma with strong ENT and ophthalmic franchises (e.g., Flogard, ophthalmic generics). Comparable as a domestic specialist with branded formulations in similar therapeutic categories.
• Micro Labs: Indian pharma with ophthalmic and ENT specialty products and a sizable domestic field presence. Comparable mid-sized specialty pharma competing in the same therapeutic categories.

Broad incumbents

• Alcon: Global leader in ophthalmic surgery and vision care, with broad surgical, pharmaceutical, and consumer-eye portfolios. Comparable as a leading specialty ophthalmic company, though at far greater scale and broader scope than Entod.
• Bausch + Lomb: Global ophthalmic major covering prescription eye drops, surgical devices, and consumer vision products. Competes with Entod in ophthalmic pharmaceutical products but operates at far greater global scale and breadth.
• Mankind Pharma: Large Indian pharma with growing specialty and OTC presence, including ENT/dermatology lines. Overlaps with Entod's domestic specialty footprint but operates at significantly larger scale with broader portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/c/EyeHealthbyENTOD
• Instagraminstagram.com/entodpharma.com
• Xx.com/EntodPharma
• Facebookfacebook.com/entodpharma
• LinkedInlinkedin.com/company/entodpharma

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Entod Pharmaceuticals